1 / 50

Title: Activities and Outcomes of Hematopoietic Cell Transplantation in Japan

This report provides an overview of the activities and outcomes of hematopoietic cell transplantation in Japan. It includes data on recipient demographics, donor types, stem cell sources, recipient age, main diseases, and survival rates.

mayers
Download Presentation

Title: Activities and Outcomes of Hematopoietic Cell Transplantation in Japan

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Title: Activities and Outcomes of Hematopoietic Cell Transplantation in Japan

  2. Introduction

  3. Annual Number of Transplant Recipients in Japan by Transplant Type 3 The Japanese Data Center for Hematopoietic Cell Transplantation

  4. Transplant Recipients in Japan, by Donor Type and Stem Cell Sources(Autologous) The Japanese Data Center for Hematopoietic Cell Transplantation

  5. Transplant Recipients in Japan, by Donor Type and Stem Cell Sources(Allogeneic) The Japanese Data Center for Hematopoietic Cell Transplantation

  6. Annual Trends in Transplants by Recipient Age at Transplant (Autologous / Allogeneic) 6 The Japanese Data Center for Hematopoietic Cell Transplantation

  7. Trends in Transplants by Stem Cell Sources and Recipient Age at Transplant 7 The Japanese Data Center for Hematopoietic Cell Transplantation

  8. Trends in Transplants for Leukemia and Malignant Lymphoma by Recipient Age at Transplant 8 The Japanese Data Center for Hematopoietic Cell Transplantation

  9. Indications for Hematopoietic Stem Cell Transplants in 1991-2017 (Age≤15) 9 The Japanese Data Center for Hematopoietic Cell Transplantation

  10. Indications for Hematopoietic Stem Cell Transplants in 1991-2017(Age≥16) 10 The Japanese Data Center for Hematopoietic Cell Transplantation

  11. Trends of Main Diseasefor Autologous Transplants in 1991-2017 (Age≤15) 11 The Japanese Data Center for Hematopoietic Cell Transplantation

  12. Trends of Main Disease for Allogeneic Transplants in 1991-2017 (Age≤15) 12 The Japanese Data Center for Hematopoietic Cell Transplantation

  13. Trends of Main Diseasefor Autologous Transplants in 1991-2017(Age≥16) 13 The Japanese Data Center for Hematopoietic Cell Transplantation

  14. Trends of Main Disease for Allogeneic Transplants in 1991-2017 (Age≥16) 14 The Japanese Data Center for Hematopoietic Cell Transplantation

  15. Stem Cell Sources for Autologous Transplants by Year 15 The Japanese Data Center for Hematopoietic Cell Transplantation

  16. Stem Cell Sources for Allogeneic Transplants by Year 16 The Japanese Data Center for Hematopoietic Cell Transplantation

  17. Stem Cell Sources for Unrelated Donor Transplants by Year 17 The Japanese Data Center for Hematopoietic Cell Transplantation

  18. Allogeneic Transplants for Age ≤15yearsby Donor Type and Graft Source 18 The Japanese Data Center for Hematopoietic Cell Transplantation

  19. Allogeneic Transplants for Age 16-50 yearsby Donor Type and Graft Source 19 The Japanese Data Center for Hematopoietic Cell Transplantation

  20. Allogeneic Transplants for Age ≥51yearsby Donor Type and Graft Source 20 The Japanese Data Center for Hematopoietic Cell Transplantation

  21. Trends in Transplants by Disease Status (Risk) at Transplant（ AML / ALL / CML / MDS ) 21 The Japanese Data Center for Hematopoietic Cell Transplantation

  22. Trends in Allogeneic Transplants by Conditioning Regimen 22 The Japanese Data Center for Hematopoietic Cell Transplantation

  23. Annual Number of Allogeneic HCTs from related donorsby Year and Donor Type(HLA-matched/HLA-non-id relative ) 23 The Japanese Data Center for Hematopoietic Cell Transplantation

  24. 100-day Survival by Year of Transplants,Donor, and Age (Autologous / Allogeneic) The Japanese Data Center for Hematopoietic Cell Transplantation

  25. One-year Survival by Year of Transplants,Donor,and Age(Autologous / Allogeneic) The Japanese Data Center for Hematopoietic Cell Transplantation

  26. 100-day Survival by Year of AllogeneicTransplants,Donor, and Stem Cell Sources (Age<50) The Japanese Data Center for Hematopoietic Cell Transplantation

  27. One-year Survival by Year of Allogeneic Transplants,Donor, and Stem Cell Sources (Age<50) The Japanese Data Center for Hematopoietic Cell Transplantation

  28. 100-day Survival by Year of Allogeneic Transplants,Donor, and Stem Cell Sources (Age≥50) The Japanese Data Center for Hematopoietic Cell Transplantation

  29. One-year Survival by Year of Allogeneic Transplants,Donor, and Stem Cell Sources (Age≥50) The Japanese Data Center for Hematopoietic Cell Transplantation

  30. 100-day Survival by Year of Transplants,Disease Status, and Age（ AML / ALL / CML / MDS ) The Japanese Data Center for Hematopoietic Cell Transplantation

  31. One-year Survival by Year of Transplants,Disease Status, and Age（ AML / ALL / CML /MDS ) The Japanese Data Center for Hematopoietic Cell Transplantation

  32. Survival after Transplants, by Donor Type and Stem Cell Sources (1991-2017) 32 The Japanese Data Center for Hematopoietic Cell Transplantation

  33. Survival after Transplants for Leukemia, 1991-2017 33 The Japanese Data Center for Hematopoietic Cell Transplantation

  34. Survival after Transplants for Malignant Lymphoma and MM/PCD, 1991-2017 34 The Japanese Data Center for Hematopoietic Cell Transplantation

  35. Survival after Autologous Transplants for Acute Leukemia by Recipient Age, 1991-2017 35 The Japanese Data Center for Hematopoietic Cell Transplantation

  36. Survival after Autologous Transplants for Malignant Lymphoma by Recipient Age, 1991-2017 36 The Japanese Data Center for Hematopoietic Cell Transplantation

  37. Survival after Autologous Transplants for MM/PCD, Age≥16 Years, 1991-2017 37 The Japanese Data Center for Hematopoietic Cell Transplantation

  38. Survival after Allogeneic Transplants for AML, Age≤15 Years, 1991-2017 38 The Japanese Data Center for Hematopoietic Cell Transplantation

  39. Survival after Allogeneic Transplantsfor AML, Age≥16 Years, 1991-2017 39 The Japanese Data Center for Hematopoietic Cell Transplantation

  40. Survival after Allogeneic Transplantsfor ALL, Age≤15 Years, 1991-2017 40 The Japanese Data Center for Hematopoietic Cell Transplantation

  41. Survival after Allogeneic Transplantsfor ALL, Age≥16 Years, 1991-2017 41 The Japanese Data Center for Hematopoietic Cell Transplantation

  42. Survival after Allogeneic Transplantsfor CML, Age≤15 Years, 1991-2017 42 The Japanese Data Center for Hematopoietic Cell Transplantation

  43. Survival after Allogeneic Transplantsfor CML, Age≥16 Years, 1991-2017 43 The Japanese Data Center for Hematopoietic Cell Transplantation

  44. Survival after Allogeneic Transplantsfor MDS, Age≤15 Years, 1991-2017 44 The Japanese Data Center for Hematopoietic Cell Transplantation

  45. Survival after Allogeneic Transplantsfor MDS, Age≥16 Years, 1991-2017 45 The Japanese Data Center for Hematopoietic Cell Transplantation

  46. Survival after Allogeneic Transplantsfor NHL, Age≤15 Years, 1991-2017 46 The Japanese Data Center for Hematopoietic Cell Transplantation

  47. Survival after Allogeneic Transplantsfor NHL, Age≥16 Years, 1991-2017 47 The Japanese Data Center for Hematopoietic Cell Transplantation

  48. Survival after Allogeneic Transplantsfor MM/PCD, Age≥16 Years, 1991-2017 48 The Japanese Data Center for Hematopoietic Cell Transplantation

  49. Survival after Allogeneic Transplantsfor AA, Age≤15 Years, 1991-2017 49 The Japanese Data Center for Hematopoietic Cell Transplantation

  50. Survival after Allogeneic Transplantsfor AA, Age≥16 Years, 1991-2017 50 The Japanese Data Center for Hematopoietic Cell Transplantation

More Related